FORT WORTH, TEXAS (Oct. 10, 2020) – Vetoquinol USA, a world-class developer of veterinarian-approved formulas for companion and large animal healthcare products, announced Rebecca Peskin joined the company as the National Marketing Manager and Blaine Godley, DVM, is now a Technical Services Veterinarian.
“Bringing Beckie and Blaine onto our team gives us a big dose of experience and expertise,” said Eric M. Alsup, DVM, Country Manager, Vetoquinol USA. “They bring both small and large animal backgrounds, which helps support the range of Vetoquinol brands. We’ll also be tapping into their experience in parasitology, which is a new strategic area of development for Vetoquinol.”
Peskin and Godley will support all the Vetoquinol brands, including: Flexadin® Advanced with UC-II® chews to support joint health in cats and dogs; ZYLKENE® supplement for dogs, cats and horses; and Folltropin® for the induction of superovulation in reproductively mature heifers and cows.
Peskin brings more than 20 years of experience working with veterinary pharmaceutical and biologics companies such as Merial, Boehringer Ingelheim and KindredBio. She has launched more than six brands during her career. In her spare time, Peskin competes in American Quarter Horse Association (AQHA) events and most recently placed in multiple events at the 2018 AQHA World Show.
Dr. Godley spent several years in small animal private practice before helping companies like Novartis Animal Health, Elanco and KindredBio in roles ranging from pharmacovigilance to leading teams of professional veterinarians. He is a native of Birmingham, Ala., a graduate of the Auburn University of College of Veterinary Medicine and completed an equine medicine internship at North Carolina State University. Dr. Godley currently lives in the Atlanta, GA, area. He will support Vetoquinol territory managers and customers across the nation in his new role.
About Vetoquinol USA
Headquartered in Fort Worth, Texas, Vetoquinol USA, Inc. is owned by Vetoquinol S.A., an independent, family-owned French pharmaceutical company founded in 1933. Dedicated exclusively to animal health, Vetoquinol USA is focused on the development, production and marketing of FDA, EPA and AAFCO-regulated pharmaceutical, nutritional and dermatological products for small and large animals. Vetoquinol’s small animal veterinary division helps pet parents support the health of their special fur-babies from birth through senior stages by delivering a full range of effective, innovative products that build on our more than 80-year legacy of leadership in the animal health market. Vetoquinol’s large animal veterinary division offers products for horses and cattle to assist owners and veterinarians with joint health, pain management, immune support, behavior and general care.
Flexadin®, UC-II®, ZYLKENE® and Folltropin® are registered trademarks of Vetoquinol USA.
© 2020 Vetoquinol USA. All rights reserved.
Latest news of vetoquinol
15 Apr 2021Clevor® (ropinirole ophthalmic solution) and ToxBuddy®, an online service to help quickly evaluate potential poisonings in dogs, are offered...
01 Apr 2021Vetoquinol represents one of the only animal health companies on the list. FORT WORTH, TEXAS (March 31, 2021) – Vetoquinol USA is one of the...